Goudet P, Cougard P, Vergès B, Murat A, Carnaille B, Calender A, Faivre J, Proye C
Service de Chirurgie Viscérale et Urgences, Hôpital Général, 3 Rue du Faubourg-Raines, BP 1519, 21033 Dijon, France.
World J Surg. 2001 Jul;25(7):886-90. doi: 10.1007/s00268-001-0046-z.
The French and Belgian GENEM study group's multiple endocrine neoplasia type I (MEN-I) database was used to evaluate trends in clinical presentation, surgical treatment of primary hyperparathyroidism (pHPT) (n = 245), and prognostic factors for hypercalcemia correction among 256 MEN-I cases. The patients were retrieved through the GENEM network from various Belgian and French institutions with the help of genetics laboratories. Among the 245 pHPT patients (96%), 42% were men. The mean age at the time of diagnosis was 39.5 +/- 13.3 years. Trends were studied for three periods: before 1986, from 1986 to 1990, and thereafter. After 1990 MEN-I patients were more often diagnosed with isolated pHPT (8%, 11%, 28%, for the three periods, respectively; p = 0.002); it was seen more often in screened patients (31%, 28%, 53%; p = 0.001), more often among those in already known MEN-I families (64%, 45%, 72%; p = 0.005), and among those with lower preoperative calcemia (2.93, 2.87, 2.79 mmol/L; p = 0.001). The age at pHPT diagnosis remained constant throughout the study. The percentage of cervical explorations dropped during the entire study (87%, 87%, 53%; p < 0.0001). After 1985 the percentage of subtotal parathyroidectomies increased (25%, 59%, 51%; p = 0.0004). Pathology disclosed more hyperplasias (59%, 85%, 74%; p = 0.008). Postoperative hypercalcemia decreased (47%, 15%, 19%; p < 0.0001); and postoperative hypocalcemia increased nonsignificantly (5%, 15%, 15%; p = 0.1). Subtotal parathyroidectomy [odds ratio (OR) 13], no MEN-I family background (OR 3), and the most recent study period (> 1985) (OR 3) were significant predictive factors of hypercalcemia correction according to the multivariate analysis. This is the first multicentric study on the management of MEN-I-related pHPT. Immediate postoperative hHPT cure increased, but only 80% of the operated patients were cured after 1990. Fifteen percent were hypocalcemic. Because MEN-I-related hHPT cure remains difficult to achieve, we advocate that subtotal parathyroidectomies be performed in specialized centers.
法国和比利时GENEM研究小组的多发性内分泌腺瘤1型(MEN-I)数据库被用于评估256例MEN-I患者的临床表现趋势、原发性甲状旁腺功能亢进症(pHPT)(n = 245)的外科治疗以及高钙血症纠正的预后因素。患者通过GENEM网络,在遗传学实验室的帮助下从比利时和法国的各个机构中检索出来。在245例pHPT患者(96%)中,42%为男性。诊断时的平均年龄为39.5±13.3岁。对三个时期的趋势进行了研究:1986年之前、1986年至1990年以及此后。1990年之后,MEN-I患者更常被诊断为孤立性pHPT(三个时期分别为8%、11%、28%;p = 0.002);在筛查患者中更常见(31%、28%、53%;p = 0.001),在已知的MEN-I家族患者中更常见(64%、45%、72%;p = 0.005),在术前血钙水平较低的患者中更常见(2.93、2.87、2.79 mmol/L;p = 0.001)。整个研究过程中pHPT诊断时的年龄保持不变。在整个研究期间,颈部探查的百分比下降(87%、87%、53%;p < 0.0001)。1985年之后,次全甲状旁腺切除术的百分比增加(25%、59%、51%;p = 0.0004)。病理检查发现更多增生(59%、85%、74%;p = 0.008)。术后高钙血症减少(47%、15%、19%;p < 0.0001);术后低钙血症无显著增加(5%、15%、15%;p = 0.1)。根据多变量分析,次全甲状旁腺切除术[比值比(OR)13]、无MEN-I家族背景(OR 3)以及最近的研究时期(>1985年)(OR 3)是高钙血症纠正的显著预测因素。这是第一项关于MEN-I相关pHPT管理的多中心研究。术后即刻高钙血症治愈率提高,但1990年之后只有80%的手术患者治愈。15%的患者出现低钙血症。由于MEN-I相关的高钙血症治愈仍然难以实现,我们主张在专业中心进行次全甲状旁腺切除术。